DANNY RYALS: Open Payments
NPI 1144315961 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,609 in 91 payments from 17 companies in 2025. Trend: 2023 $1,795 · 2024 $1,540 · 2025 $1,609
Food & beverage: $1,609
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $351 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 23 | $297 |
| Merck Sharp & Dohme LLC | 9 | $208 |
| Amgen Inc. | 24 | $169 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Philips North America LLC | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| SCPHARMACEUTICALS INC. | 3 | $45 |
| Esperion Therapeutics, Inc. | 3 | $44 |
Products named: JARDIANCE, AVEIR, VERQUVO, REPATHA, LEQVIO, JOT DX, Kerendia, ELIQUIS.
Industry payments across LA — which companies pay providers there.
